<p>Abstract</p><p>Denna uppsats ska utgå från den generella problematiken och komplexiteten om ansvarsfördelningen mellan stat och familj när det gäller barnets bästa. Mer specifikt vill jag närmare titta på vad som kan hända när denna fråga ställs på sin spets: i detta fall när barn befinner sig i någon form av krissituation och frågan om ett offentligt ingripande av något slag aktualiseras. Frågor om vad som är barnets bästa uppstår i sådana fall och den myndighet som har ansvar för att avgöra detta är Socialtjänsten. Socialtjänstens arbete handlar också om att undersöka om barnet får sina behov tillgodosedda i hemmamiljön. Utgångsläget skall vara att familjen ska kunna lösa sina problem på egen hand, men om det bedöms nödvändigt ska samhället ingripa. Här kan frågan om ett omhändertagande av barn vara aktuell.</p><p>Med utgångspunkt i frågan om ansvarsfördelningen mellan det offentliga och familjen när det gäller barnets bästa, är syftet med min uppsats att undersöka hur en offentlig myndighet på lokal nivå agerar när det kommer till deras kännedom att ett barn far illa och behöver hjälp. Jag vill få en bild av och exempel på hur samhällets ansvar för barnets bästa kan tillgodoses. Det kan dock inte vara helt problemfritt med att veta vad barnets bästa är samt hur man ska gå tillväga för att på ett tillfredsställande sätt kunna tillgodose barnets behov. Undersökningen berör också utvecklingen på en nationell nivå när det gäller förskjutningar i ansvarsfördelningen mellan det privata och det offentliga. Följande behandlar jag i denna uppsats:</p><p>- Vilka olika typer av fall hamnar på myndighetens bord?</p><p>- Hur hanteras dessa fall?</p>

Increased vascularization (angiogenesis) is a required adaptation for sustained tumor growth, and the primary mediator of de novo blood vessel formation is vascular endothelial growth factor (VEGF). The central transcriptional activator of VEGF is hypoxia inducible factor-1 (HIF-1), a heterodimeric transcription factor composed of an inducible HIF-1alpha subunit and a constitutively expressed HIF-1beta subunit. In addition to HIF-1, it has recently been reported that signal transducer and activator of transcription 3 (Stat3) is required for VEGF production and angiogenesis. Although it is known that Stat3 is an important mediator of many of the oncogenic signaling pathways that regulate HIF-1alpha, it was not known if Stat3 regulates HIF-1alpha. To answer this important question, the effect of blocking Stat3 signaling on both HIF-1alpha and VEGF expression was examined. Treatment of cells with IL-6, a potent activator of Stat3, resulted in HIF-1alpha and VEGF induction during normoxia. By blocking protein synthesis with cycloheximide, it was determined that IL-6 induction of HIF-1alpha resulted from increased translation. When Stat3 was silenced with siRNA, both basal level expression and IL-6 induction of HIF-1alpha and VEGF were significantly reduced. Furthermore, it is likely that Stat3 is required for HIF-1alpha induction by a variety of growth signals, as both HIF-1alpha and VEGF expression resulting from EGF and heregulin were abolished when Stat3 signaling was blocked. Because we had observed that Stat3 was required for induction of HIF-1alpha by growth signals, we wanted to determine if Stat3 was also required for HIF-1a induction by hypoxia. When Stat3 was silenced and cells exposed to hypoxia, HIF-1a expression was again abolished. Furthermore, the hypoxic induction of VEGF and MMP-2 was also prevented.

Interleukins, cytokines secreted by leukocytes, are predominant messengers modulating immune responses. Interleukin-27 (IL-27), a key immunomodulatory cytokine, functions to induce both pro- and anti-inflammatory effects in various immune cells. IL-27 is a heterodimeric cytokine, composed of IL-27p28 and Epstein-Bar virus induced gene 3 (EBI3) subunits, and binds to a receptor composed of IL-27Rα (WSX-1) and gp130. Initial studies focused on describing IL-27 functions in skewing T helper cell development to a Th1 response, with few reports on functions in monocytes. Thus, in this thesis, I aimed to characterize novel functions of IL-27 in innate immune responses of monocytes. I initially established that IL-27 induced a pro-inflammatory cytokine profile (IL-6, IP-10, MIP-1α, MIP-1β, and TNF-α) mediated via STAT1/3 and NF-κB signaling pathways. Further investigation led to the discovery that IL-27 could enhance LPS responses via upregulation of TLR4 expression and NF-κB signaling. Together, these studies described novel signaling mechanisms (NF-κB and JAK/STAT crosstalk) and gene targets (cytokines and TLR4) of IL-27 that drive inflammatory responses. In continuing the quest for novel IL-27 functions in innate immunity, I reported IL-27 can upregulate expression of the IFN-responsive, antiviral protein called BST-2. My results showing IL-27-induced expression of BST-2 mRNA and cell surface protein were supported by previous studies reporting IL-27-induced expression of other antiviral molecules. Furthermore, previous studies showed IL-27 could inhibit HIV replication via antiviral gene induction, pointing to potential for IL-27 immunotherapies. In light of the posited role for IL-27 in therapeutics, it became inherently critical to describe how IL-27 functions in the setting of HIV infection. Thus, in my final thesis chapters, I described the effect of HIV infection on IL-27 expression and functions, addressing a substantial void in literature. Interestingly, a trend of decreased IL-27 expression and significant impairment of IL-27-induced gene expression was observed in HIV infection. Therefore, decreased circulating IL-27 and decreased IL-27 responsiveness may collectively dysregulate IL-27 function in HIV. This thesis describes novel, IL-27-driven, proinflammatory responses, and highlights impairment of IL-27 function in HIV infection. This work bridged a gap in knowledge of IL-27 functions in monocytes and highlighted multifaceted mechanisms underlying immunoregulation by IL-27. / Thesis (Ph.D, Microbiology & Immunology) -- Queen's University, 2012-04-12 13:07:50.588

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal

The JAK/STAT pathway is but one of the signal transduction cascades responsible for proper development and homeostasis. Gain-of-function mutations of pathway components are causative agents of several leukemias, highlighting the necessity for proper regulation of signal transduction. Drosophila presents an attractive model to study JAK/STAT signaling because mutations in the pathway behave in an analogous manner. Furthermore, the Drosophila cascade is much simpler as only one of each component required for activation has been characterized; whereas in mammals, there are many ligands, receptors, 4 JAKs and 7 STATs.Suppressors of Cytokine Signaling (SOCS) are one family of molecules which regulate JAK/STAT signaling via a negative feedback loop. All SOCS share a distinct modular domain architecture, which we exploited to locate three putative SOCS homologues within the Drosophila genome. I present the identification and initial characterization of one of these homologues, Socs44A. I show that Socs44A is not responsive to or dependent on JAK activity. However, I demonstrate that Socs44A is capable of downregulating JAK/STAT signaling in the developing wing but not inoogenesis, indicating that its ability to regulate the pathway is tissue specific, a phenomenon observed in the mammalian model.Signal transduction pathways are integrated at multiple levels. This interplay allows for combinatorial signaling, resulting in a higher order of complexity in the signals that can be received and interpreted by a cell. Well documented are the interactions between the JAK/STAT and the EGFR/MAPK pathways. In this work, I show that Socs44A can genetically interact with, and upregulate, the EGFR/MAPK pathway, analogous to a recent report involving SOCS-3.Starting with the Drosophila genome sequence, I initiated a reverse genetic approach to studying the function of the Socs44A locus. During the course of this investigation, I designed and implemented a novel post-processor of the BLAST algorithm, called Multi-BLAST, which facilitates retrieval of multiple domain sequences from public databases. In what would have been the ultimate achievement of this study, I attempted two mutagenesis screens designed to isolate Socs44A loss-of-function alleles. Progress on these screens is reported.

Equine herpesvirus-1 (EHV-1) is one of the major viral pathogens causing respiratory disease, abortion, perinatal mortality and neurologic disease among horses resulting in significant economic losses to the equine industry. The virus can also remain latent in the horses and recrudesce at any time. Type-I interferons (IFNs) act as a first line of defense against many viral infections. In this study we investigated the type-I IFN response against the neuropathogenic T953 strain of EHV-1 in equine endothelial cells (EECs). The results showed that after a transient induction of IFN-β mRNA as well as protein at an early time (3h) post infection (p.i.), T953 strain of EHV-1 suppressed further induction of IFN-β at later times (12h onwards). Studies were done to confirm that the suppression of type-I IFN induction at later time points was not due to the normal IFN-β induction kinetics, it was rather because of the active interference by the virus. Investigation of the mechanisms by which T953 interferes with IFN-β production revealed that the virus degraded the endogenous level of the transcription factor, interferon regulatory factor 3 (IRF-3) and also down-regulated the activation of IRF-3 followed by its accumulation in the nucleus. However, T953 infection caused degradation of nuclear factor κB (NF-κB) inhibitory protein IκBα and also induced p50 subunit to translocate into nucleus from cytoplasm suggesting activation of NF-κB signaling. This also indicated that inhibition in the type-I IFN production was probably not due to the inhibition of NF-κB. The results of these studies also indicated that T953 virus was resistant to the biological effect of the recombinant equine IFN-α in vitro. Investigation of the reason of this resistance showed that T953 virus interfered with the cellular JAK-STAT signaling mechanism by which type-I IFN exerts its antiviral effect. Moreover, the studies revealed that downstream of the JAK-STAT signaling, T953 virus also inhibited the expression of cellular antiviral proteins including interferon stimulated gene 56 (ISG56) and viperin. Altogether, these data indicate that the T953 strain of EHV-1 interfered with the host cell innate immune responses by modulating type-I IFN mediated immune responses at multiple levels in vitro.

In the Drosophila testis, sperm are derived from germline stem cells (GSCs) which undergo a stereotyped pattern of divisions and differentiation. The somatic cells at the tip of the testis form the hub, which is the niche for both the somatic cyst stem cells (CySCs) and GSCs. The hub expresses Upd, a ligand for the JAK/STAT pathway that has roles in the maintenance of CySCs and GSCs. Male mutants of upd3, another ligand of the JAK/STAT pathway, become sterile much earlier than the wild-type, leading to the hypothesis that similar to upd, upd3 also promotes the self-renewal of stem cells in testis. It was found here that upd3 is also expressed in the hub, and that mutants of upd3 have fewer CySCs and GSCs. Using a GFP reporter of the JAK/STAT pathway, it was found that the JAK/STAT pathway is not only activated in the stem cells, consistent with its known function in the maintenance of stem cells, but is also activated in the elongated cyst cells that encapsulate late stage differentiating spermatids. The reduction of JAK/STAT activity in the somatic cyst cells led to impaired spermatid individualization, a late stage of spermatogenesis during which the syncytial spermatids are separated. The impairment of individualization was shown by the loss of three characteristic structures: individualization complexes (ICs), cystic bulges (CBs), and waste bags (WBs). The failure of IC formation implies STAT activity is required for the initiation of individualization, and the loss of CBs and WBs suggests STAT activity is required for the progression of individualization. Activation of caspases in elongated spermatids is known to be required for individualization. The reduction of JAK/STAT activity in cyst cells almost completely eliminated the activation of two effector caspases: drICE and DCP-1. It was concluded that JAK/STAT activity in somatic cyst cells promotes individualization by stimulating caspase activity in spermatids. The JAK/STAT pathway is not only required for the maintenance of stem cells at the tip, but also required for individualization away from the tip during late differentiation, thus is reutilized in Drosophila spermatogenesis.

The duration and intensity of the JAK/stat signaling must be tightly regulated to prevent excessive transcriptional response and to reset the pathway to receive additional signals. Socs are the largest class of these regulators in mammals. Eight Socs genes have been found in mammals. CIS, and SOCS1-3, the canonical Socs, are transcriptionally activated by and down-regulate the JAK signaling. Socs4-7, the non-canonical Socs, are less studied and their relationship with the JAK/STAT pathway has not been well established. The Drosophila genome encodes three non-canonical Socs homologues, Socs16D, Socs36E, and Socs44A. Expression of Socs36E is controlled by the JAK pathway and misexpression causes phenotypes similar to that from reduction of JAK in both ovary and wing, which may make it functionally more similar to the canonical Socs. Expression of Socs44A is not controlled by the JAK pathway and misexpression causes JAK mutant phenotypes in wing but not in ovary. Imprecise excision mutants of the three Socs genes have been generated by us and have no visible phenotypes. The mutants of Socs36E and Socs44A significantly enhance the tumor formation in hopTum-l mutant, a gain-of-function mutation of the JAK/STAT pathway. The function of Drosophila Socs will be further studied with different strategies.

Plasmacytoid dendritic cells (pDC) are a specialized group of circulating dendritic cells that respond to viral nucleic acids with Type I IFN production as well as other cytokine and chemokines. These pDC responses lead to the production of antiviral molecules and recruitment of defense cells. During zoonotic B virus infection, a simplex virus of the subfamily Alphaherpesviridae, our lab has observed that infected individuals who succumb to infection have little-to-no-antibody or cell-mediated defenses. To identify whether this was partly due to failure of pDCs to produce antiviral interferon responses or produce chemokine and cytokines, we tested the hypothesis that B virus modulates the IFN response during zoonotic infection by blocking pDC activation and subsequent IFN signaling pathways to circumvent host defenses, while these pathways remain intact in the macaque hosts. We showed that human pDCs respond to B virus through the production of IFN-a, IL-1a, IL-6, TNF-a, MIP-1a/b and IP-10. Human pDCs co-cultured with B virus infected fibroblasts produced fewer cytokines and at lower levels. The macaque response to B virus was measured using PBMCs, as there are no specific reagents available to enrich macaque pDCs. Human and macaque PBMCs produced IFN-a when exposed directly to B virus infected lysates. Co-cultures of PBMCs with B virus infected fibroblasts from both hosts failed to produce any significant amounts of IFN-a. To quantify the antiviral effects of PBMC induced IFN-a, we measured B virus titers after exposure to supernatants from B virus exposed PBMCs, PBMC co-cultures with infected fibroblasts and exogenous recombinant Type I IFN. Our data further suggest that B virus resistance was not due to virus specific blockade of the Type I IFN signaling pathway because STAT-1 was activated in infected fibroblasts when treated with Type I IFNs. These data demonstrate for the first time that B virus replication is unimpeded in the presence of any source of IFN-a in either host cell type. In conclusion, this dissertation shows that the IFN-a production by both hosts in response to B virus is similar and that IFN-a treatment of B virus infected fibroblasts did not reduce B virus replication.

Alliansbildningsbeteende är ett viktigt och intressant ämne inom internationell politik och i internationella relationer.  Enligt den traditionella maktbalansteorin allierar sig stater med andra stater för att balansera mot externa hot. I Steven R. Davids ”omnibalancing-teori” hävdas däremot att statsledare i tredjevärlden allierar sig med stater för att bekämpa interna hot. I föreliggande examensarbete, som är en fallstudie, är ambitionen att visa att turkiska republikens relation med Kurdistanregionen i Irak är ett fall av ”omnibalancering” såtillvida att Turkiet därigenom söker hålla den kurdiska rörelsen på hemmaplan i schack. Därför står Turkiet emot ett kurdiskt självstyre i Västra Kurdistan, syriska Kurdistan (Rojava), som har ideologiska kopplingar till den kurdiska rörelsen i turkiska Kurdistan (Norra Kurdistan). Med hänsyn till andra faktorer i relationer mellan stater (t ex i Turkiets relation till Södra Kurdistan) kan man uppmärksamma ekonomi- och energifrågorna. Vidare visar resultaten av fallstudier att etniska problem som ett internt hot påverkar statens utrikespolitik och alliansbeteende.